Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,585 | 2 | 54.1% |
| Food and Beverage | $1,324 | 38 | 45.2% |
| Education | $17.90 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,527 | 10 | $0 (2020) |
| Daiichi Sankyo Inc. | $446.24 | 3 | $0 (2018) |
| Purdue Pharma L.P. | $359.73 | 10 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $168.81 | 4 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $114.44 | 2 | $0 (2019) |
| Amgen Inc. | $97.20 | 1 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $69.30 | 2 | $0 (2024) |
| RedHill Biopharma Inc. | $47.88 | 3 | $0 (2021) |
| Egalet US Inc | $30.59 | 1 | $0 (2017) |
| US WorldMeds, LLC | $14.06 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.19 | 1 | Collegium Pharmaceutical, Inc. ($58.19) |
| 2021 | $45.20 | 4 | RedHill Biopharma Inc. ($29.64) |
| 2020 | $62.76 | 4 | PFIZER INC. ($30.46) |
| 2019 | $117.77 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($100.98) |
| 2018 | $264.70 | 5 | Teva Pharmaceuticals USA, Inc. ($131.00) |
| 2017 | $2,378 | 26 | PFIZER INC. ($1,480) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $58.19 | General |
| Category: Opioid Analgesic | ||||||
| 10/06/2021 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: Pain | ||||||
| 09/30/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Opioid Antagonist | ||||||
| 09/13/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Opioid Antagonist | ||||||
| 05/13/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Chronic Pain | ||||||
| 10/13/2020 | RedHill Biopharma Inc. | movantik (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Opioid Antagonist | ||||||
| 02/11/2020 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 01/25/2020 | US WorldMeds, LLC | MYOBLOC (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neurology | ||||||
| 01/14/2020 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 12/03/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 03/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug) | Food and Beverage | In-kind items and services | $100.98 | General |
| Category: PAIN MEDICINE | ||||||
| 12/13/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $131.00 | General |
| Category: Central Nervous System | ||||||
| 10/10/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Pain Management | ||||||
| 09/11/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | LUCEMYRA (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: PAIN MEDICINE | ||||||
| 06/26/2018 | Collegium Pharmaceutical, Inc. | XTAMPZAER (Drug) | Food and Beverage | Cash or cash equivalent | $11.11 | General |
| Category: Opioid Analgesic | ||||||
| 03/29/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $97.20 | General |
| 12/01/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/30/2017 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $431.36 | General |
| Category: Pain Management | ||||||
| 11/18/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Pain Medicine | ||||||
| 09/27/2017 | Abbott Laboratories | DRG IPGs (Device) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/25/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Food and Beverage | Cash or cash equivalent | $2.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/14/2017 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $1.82 | General |
| 07/28/2017 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 07/27/2017 | Purdue Pharma L.P. | HYSINGLA ER (Drug) | Food and Beverage | Cash or cash equivalent | $2.04 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/10/2017 | Teva Pharmaceuticals USA, Inc. | AMRIX (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 22 | 1,375 | 7,511 | $1.6M | $312,086 |
| 2020 | 19 | 1,429 | 7,576 | $1.7M | $311,610 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 141 | 430 | $282,080 | $75,015 | 26.6% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2021 | 84 | 222 | $190,855 | $39,806 | 20.9% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Office | 2021 | 140 | 419 | $171,790 | $35,478 | 20.7% |
| 77002 | Fluoroscopic guidance for insertion of needle | Office | 2021 | 98 | 309 | $92,700 | $26,321 | 28.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 181 | 4,544 | $257,361 | $24,207 | 9.4% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 93 | 110 | $107,256 | $20,154 | 18.8% |
| 64479 | Injections of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2021 | 48 | 88 | $72,160 | $16,284 | 22.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 177 | $29,028 | $11,383 | 39.2% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Office | 2021 | 91 | 108 | $52,644 | $11,260 | 21.4% |
| 64490 | Injections of upper or middle spine facet joint using imaging guidance, single level | Office | 2021 | 42 | 57 | $54,940 | $8,748 | 15.9% |
| 64480 | Injections of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | Office | 2021 | 43 | 79 | $38,868 | $8,110 | 20.9% |
| 64495 | Injections of lower or sacral spine facet joint using imaging guidance, third and any additional level(s) | Office | 2021 | 56 | 58 | $28,372 | $6,126 | 21.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 53 | 131 | $32,226 | $6,126 | 19.0% |
| 64491 | Injections of upper or middle spine facet joint using imaging guidance, second level | Office | 2021 | 41 | 55 | $26,240 | $4,533 | 17.3% |
| 64445 | Injection of anesthetic agent and/or steroid into sciatic nerve of lower back and leg | Office | 2021 | 28 | 45 | $18,860 | $4,361 | 23.1% |
| 64417 | Injection of anesthetic agent and/or steroid into axillary nerve of upper arm and shoulder | Office | 2021 | 14 | 22 | $21,648 | $3,093 | 14.3% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 17 | 34 | $20,910 | $2,754 | 13.2% |
| 64420 | Injection of anesthetic agent and/or steroid into single intercostal nerve of rib | Office | 2021 | 15 | 29 | $12,300 | $2,321 | 18.9% |
| 64492 | Injections of upper or middle spine facet joint using imaging guidance, third and any additional level(s) | Office | 2021 | 22 | 26 | $12,710 | $2,166 | 17.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $8,528 | $2,088 | 24.5% |
| 64421 | Injection of anesthetic agent and/or steroid into multiple intercostal nerves of ribs for regional nerve block | Office | 2021 | 15 | 58 | $39,360 | $1,581 | 4.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 66 | 484 | $39,770 | $171.75 | 0.4% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 133 | 417 | $274,208 | $70,277 | 25.6% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2020 | 89 | 216 | $185,689 | $36,848 | 19.8% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 130 | 406 | $166,870 | $32,468 | 19.5% |
About Dr. Thomas Duc, MD
Dr. Thomas Duc, MD is a Pain Medicine healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871549865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Duc, MD has received a total of $2,927 in payments from pharmaceutical and medical device companies, with $58.19 received in 2024. These payments were reported across 42 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,585).
As a Medicare-enrolled provider, Duc has provided services to 2,804 Medicare beneficiaries, totaling 15,087 services with total Medicare billing of $623,696. Data is available for 2 years (2020–2021), covering 41 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Charleston, SC
- Active Since 05/25/2006
- Last Updated 08/16/2012
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871549865
Products in Payments
- EMBEDA (Drug) $1,337
- Morphabond ER (Drug) $443.29
- HYSINGLA ER (Drug) $342.16
- LYRICA (Drug) $143.10
- AJOVY (Drug) $131.00
- LUCEMYRA (Drug) $114.44
- Belbuca (Drug) $58.19
- AMRIX (Drug) $37.81
- Movantik (Drug) $32.59
- SPRIX (Drug) $30.59
- movantik (Drug) $18.24
- MYOBLOC (Biological) $14.06
- DRG IPGs (Device) $12.52
- ZOHYDRO ER (Drug) $12.34
- BELBUCA (Drug) $11.80
- XTAMPZAER (Drug) $11.11
- LORZONE (Drug) $10.62
- OXYCONTIN (Drug) $7.61
- NALOCET (Drug) $3.76
- BUTRANS (Drug) $3.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Charleston
Timothy Deer, Md, MD
Pain Medicine — Payments: $3.9M
Christopher Kim, Md, MD
Pain Medicine — Payments: $132,348
Dr. Lucas Bracero, Md, Mba, MD, MBA
Pain Medicine — Payments: $19,533
David Arcella, Md, MD
Pain Medicine — Payments: $18,415
Andrew Mendelson
Pain Medicine — Payments: $16,599
Dr. Justin Wikle, M.d, M.D
Pain Medicine — Payments: $5,376